Wordt geladen...
Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice
Alcohol relapse is a treatment goal for alcohol dependence and the target for medications’ development. Clinically utilized nalfurafine (NFF) is a potent and selective kappa-opioid receptor (KOP-r) agonist, with fewer side effects (e.g., sedation or anhedonia) than classic KOP-r full agonists. We ha...
Bewaard in:
| Gepubliceerd in: | Brain Res |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6779526/ https://ncbi.nlm.nih.gov/pubmed/31469985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2019.146410 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|